- Home
- NHC
as of 03-11-2026 3:59pm EST
National Healthcare Corp provides long-term care facilities. Its principal business includes operating skilled nursing facilities, assisted living facilities, independent living facilities, and home care programs. The company's activities include providing sub-acute and post-acute skilled nursing care, intermediate nursing care, rehabilitative care, memory and Alzheimer's care, senior living services, and home health care services. In addition, the company also provides management services, accounting, and financial services, as well as insurance services to third-party operators of healthcare facilities. Its reportable segments include Inpatient services and Home care and hospice services. The majority of revenue is derived from the Inpatient services segment.
| Founded: | 1971 | Country: | United States |
| Employees: | N/A | City: | MURFREESBORO |
| Market Cap: | 2.7B | IPO Year: | 1997 |
| Target Price: | N/A | AVG Volume (30 days): | 59.4K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | Dividend Payout Frequency: | monthly | |
| EPS: | 7.67 | EPS Growth: | 17.46 |
| 52 Week Low/High: | $89.14 - $174.54 | Next Earning Date: | 06-01-2026 |
| Revenue: | $1,517,781,000 | Revenue Growth: | 16.09% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
| P/E Ratio: | 20.61 | Index: | N/A |
| Free Cash Flow: | 148.6M | FCF Growth: | +86.48% |
Stock Insider Trading Activity of National HealthCare Corporation (NHC)
Sr.VP Operations
Avg Cost/Share
$139.42
Shares
2,454
Total Value
$342,136.68
Owned After
0
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Shelly Timothy J. | NHC | Sr.VP Operations | Dec 17, 2025 | Sell | $139.42 | 2,454 | $342,136.68 | 0 |
Earnings Transcripts
SEC 8-K filings with transcript text
2025 Q4 Q4 2025 Earnings
8-K SELL Feb 27, 2026 · 100% conf.
Q4 2025 Earnings
8-K SELLFeb 27, 2026 · 100% conf.
1D
-0.14%
$163.47
5D
-2.58%
$159.48
20D
-3.62%
$157.77
nhc20260225_8k.htm
false 0001047335
0001047335
2026-02-27 2026-02-27
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 27, 2026 (February 26, 2026)
NATIONAL HEALTHCARE CORPORATION
(Exact name of registrant as specified in its charter)
Delaware
(State or other jurisdiction of
incorporation)
001-13489
(Commission File Number)
52-2057472
(I.R.S. Employer Identification
No.)
100 E. Vine Street
Murfreesboro, Tennessee
(Address of Principal Executive
Offices)
37130
(Zip Code)
Registrant’s telephone number, including area code: (615) 890-2020
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Exchange Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which
registered
Common Stock, $.01 par value
NHC
NYSE American
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1988 or Rule 12b-2 of the Securities Exchange Act of 1934. Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial standards pursuant to Section 13(a) of the Exchange Act. ☐
ITEM 2.02. RESULTS OF OPERATIONS AND FINANCIAL CONDITION
National HealthCare Corporation (“NHC”) issued a press release on February 26, 2026, announcing its December 31, 2025 earnings. The entire press release is attached as Exhibit 99.1 and is incorporated by reference herein.
ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS.
(d)
Exhibits.
Exhibit No.
Description of Exhibit
99.1
Copy of press release issued on February 26, 2026 by National HealthCare Corporation announcing December 31, 2025 earnings.
104
Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: February 27, 2026
NATIONAL HEALTHCARE CORPORATION
By:/s/
Brian F. Kidd
Name: Brian F. Kidd
Title: Senior VP/Chief Financial Officer
2025 Q3 Q3 2025 Earnings
8-K Nov 7, 2025
Q3 2025 Earnings
8-KNov 7, 2025
nhc20251106c_8k.htm
false 0001047335
0001047335
2025-11-07 2025-11-07
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 7, 2025 (November 7, 2025)
NATIONAL HEALTHCARE CORPORATION
(Exact name of registrant as specified in its charter)
Delaware
(State or other jurisdiction of
incorporation)
001-13489
(Commission File Number)
52-2057472
(I.R.S. Employer Identification
No.)
100 E. Vine Street
Murfreesboro, Tennessee
(Address of Principal Executive
Offices)
37130
(Zip Code)
Registrant’s telephone number, including area code: (615) 890-2020
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Exchange Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, $.01 par value
NHC
NYSE American
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1988 or Rule 12b-2 of the Securities Exchange Act of 1934. Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial standards pursuant to Section 13(a) of the Exchange Act. ☐
ITEM 2.02. RESULTS OF OPERATIONS AND FINANCIAL CONDITION
National HealthCare Corporation (“NHC”) issued a press release on November 7, 2025, announcing its September 30, 2025 earnings. The entire press release is attached as Exhibit 99.1 and is incorporated by reference herein.
ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS.
(d) Exhibits.
Exhibit No.
Description of Exhibit
99.1
Copy of press release issued on November 7, 2025 by National HealthCare Corporation announcing September 30, 2025 earnings.
104
Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: November 7, 2025
NATIONAL HEALTHCARE CORPORATION
By:
/s/
Brian F. Kidd
Name:
Title:
Brian F. Kidd
Senior VP/Chief Financial Officer
2025 Q2 Q2 2025 Earnings
8-K Aug 8, 2025
Q2 2025 Earnings
8-KAug 8, 2025
nhc20250806_8k.htm
false 0001047335
0001047335
2025-08-08 2025-08-08
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 8, 2025 (August 8, 2025)
NATIONAL HEALTHCARE CORPORATION
(Exact name of registrant as specified in its charter)
Delaware
(State or other jurisdiction of
incorporation)
001-13489
(Commission File Number)
52-2057472
(I.R.S. Employer Identification
No.)
100 E. Vine Street
Murfreesboro, Tennessee
(Address of Principal Executive
Offices)
37130
(Zip Code)
Registrant’s telephone number, including area code: (615) 890-2020
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Exchange Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, $.01 par value
NHC
NYSE American
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1988 or Rule 12b-2 of the Securities Exchange Act of 1934. Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial standards pursuant to Section 13(a) of the Exchange Act. ☐
ITEM 2.02.
RESULTS OF OPERATIONS AND FINANCIAL CONDITION
National HealthCare Corporation (“NHC”) issued a press release on August 8, 2025, announcing its June 30, 2025 earnings. The entire press release is attached as Exhibit 99.1 and is incorporated by reference herein.
ITEM 9.01.
FINANCIAL STATEMENTS AND EXHIBITS.
(d) Exhibits.
Exhibit No.
Description of Exhibit
99.1
Copy of press release issued on August 8, 2025 by National HealthCare Corporation announcing June 30, 2025 earnings.
104
Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: August 8, 2025
NATIONAL HEALTHCARE CORPORATION
By:
/s/ Brian F. Kidd
Name:
Title:
Brian F. Kidd
Senior VP/Chief Financial Officer
Compare NHC vs Leading Stocks
See how NHC stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "NHC National HealthCare Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.